Delayed neurological deterioration after subarachnoid haemorrhage (Q38169976)

30 August 2017

title

Delayed neurological deterioration after subarachnoid haemorrhage (English)

1 reference

30 August 2017

R Loch Macdonald

1

1 reference

30 August 2017

language of work or name

English

0 references

publication date

10 December 2013

1 reference

30 August 2017

published in

Nature Reviews Neurology

1 reference

30 August 2017

volume

10

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

44-58

1 reference

Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Lifetime cost of stroke in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Manifestations of the hyperadrenergic state after acute brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Relationship between sympathetic nervous activity and inflammatory response after subarachnoid hemorrhage in a perforating canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Rebleeding after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Clinical outcome prediction in aneurysmal subarachnoid hemorrhage using Bayesian neural networks with fuzzy logic inferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

The importance of early brain injury after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Acute postoperative neurological deterioration associated with surgery for ruptured intracranial aneurysm: incidence, predictors, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Costs of vasospasm in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Locally-administered Intrathecal Thrombolytics Following Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Acute hypoperfusion immediately after subarachnoid hemorrhage: a xenon contrast-enhanced CT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Acute microvascular platelet aggregation after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Mechanisms of microthrombi formation after experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Microemboli in aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Blood coagulation and fibrinolysis after experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Blood-brain barrier damage during the acute stage of subarachnoid hemorrhage, as exemplified by a new animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Time-dependent alterations in functional and pharmacological arteriolar reactivity after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Molecular mechanisms of cerebral vasospasm following aneurysmal SAH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Inflammation and cerebral vasospasm after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

A review of hemoglobin and the pathogenesis of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Monoclonal antibodies against ICAM-1 and CD18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of interferon-β on neuroinflammation, brain injury and neurological outcome after experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Mechanisms, challenges and opportunities in stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

The immunology of stroke: from mechanisms to translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Neurovascular protection reduces early brain injury after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Blood-brain barrier disruption following subarchnoid hemorrhage may be faciliated through PUMA induction of endothelial cell apoptosis from the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Blood-brain barrier breakdown in acute and chronic cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Inversion of neurovascular coupling by subarachnoid blood depends on large-conductance Ca2+-activated K+ (BK) channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Predicting the lack of development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Prospective evaluation of multidetector-row CT angiography for the diagnosis of vasospasm following subarachnoid hemorrhage: a comparison with digital subtraction angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Diagnosing delayed cerebral ischemia with different CT modalities in patients with subarachnoid hemorrhage with clinical deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Vasospasm after SAH due to aneurysm rupture of the anterior circle of Willis: value of TCD monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Evidence-based cerebral vasospasm surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Continuous EEG monitoring in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Monitoring and detection of vasospasm II: EEG and invasive monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Subarachnoid Hemorrhage International Trialists data repository (SAHIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Involvement of Rho-kinase in tumor necrosis factor-alpha-induced interleukin-6 release from C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

The protective effect of dantrolene on ischemic neuronal cell death is associated with reduced expression of endoplasmic reticulum stress markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a phase IIa study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Treatment of cerebral vasospasm with biocompatible controlled-release systems for intracranial drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Magnesium sulfate for the treatment of eclampsia: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Magnesium for aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Magnesium neuroprotection is limited in humans with acute brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Anemia and transfusion after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Hemodynamic management of subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Critical care guidelines on the endovascular management of cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

A randomized controlled trial of prophylactic intra-aortic balloon counterpulsation in high-risk aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Longitudinal in vivo and in vitro time-course study of chronic cerebrovasospasm in the rabbit basilar artery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Calcium antagonists for aneurysmal subarachnoid haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: with a case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Systemic complement depletion inhibits experimental cerebral vasospasm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Early detection of vasospasm after acute subarachnoid hemorrhage using continuous EEG ICU monitoring

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Antiplatelet therapy for aneurysmal subarachnoid haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Diffusion and perfusion MRI in patients with ruptured and unruptured intracranial aneurysms treated by endovascular coiling: complications, procedural results, MR findings and clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Cyclosporine A prevents neurological deterioration of patients with SAH--a preliminary report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.246

Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study

31 March 2020

1 reference

12 December 2020

Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: current status

1 reference

12 December 2020

The calmodulin antagonist trifluoperazine provides mild prophylactic protection against cerebral vasospasm after subarachnoid hemorrhage, but no therapeutic value

1 reference

12 December 2020

Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management.

1 reference

12 December 2020

New Regulatory, Signaling Pathways, and Sources of Nitric Oxide

1 reference

12 December 2020

A Clinical Review of Cerebral Vasospasm and Delayed Ischaemia Following Aneurysm Rupture

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs used as a treatment modality in subarachnoid hemorrhage

1 reference

12 December 2020

Reperfusion of the brain after global ischemia: hemodynamic disturbances

1 reference

12 December 2020

10.1038/NRNEUROL.2013.246

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1039617511

0 references

1 reference